— Organigram (NASDAQ: OGI) reported a net loss from continuing operations of $22.46 million for the fourth quarter of 2019, vs. profit of $18.9 million last year.
— Loss per share was $0.14, compared to earnings of $0.12 per share in the year-ago period
— Fourth-quarter net revenues surged to $16.3 million from $3.2 million last year
— Gross margin, before fair value changes to biological assets and inventories, dropped to $0.7 million from $1.6 million last year
— Adjusted EBITDA was (-)$7.9 million during the three-month period, compared $0.3 million a year earlier
— In the first quarter of 2020, net revenue is expected to increase sequentially on higher retail sales and wholesale revenue
— First-quarter gross margin, before fair value changes to biological assets and inventories, is anticipated to grow sequentially
— Expects the increased efficiencies and economies of scale to reduce cultivation costs in the first quarter, compared to Q4
Most Popular
Adobe (ADBE) to report Q3 earnings on Sept 12. Here’s what to expect
After delivering record-high revenues in the second quarter, Adobe Inc. (NASDAQ: ADBE) is gearing up to report third-quarter results next week. The design software maker has effectively integrated advanced AI
A look at Campbell Soup’s (CPB) expectations for fiscal year 2025
Shares of Campbell Soup Company (NASDAQ: CPB) rose over 1% on Friday. The stock has gained 21% over the past three months. The company delivered sales and earnings growth for
DOCU Earnings: DocuSign Q2 2025 profit jumps on higher revenues
DocuSign, Inc. (NASDAQ: DOCU) reported a sharp increase in adjusted earnings for the second quarter of 2025. The bottom line benefitted from a 7% increase in revenues. The eSignature service
Comments
Comments are closed.